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The regulatory pathways necessary for the mainte-
nance of adult hematopoietic stem cells (HSCs)
remain poorly defined. By using loss-of-function
approaches, we report a selective and cell-autono-
mous requirement for the p300/CBP-binding tran-
scriptional coactivator Cited2 in adult HSC mainte-
nance. Conditional deletion of Cited2 in the adult
mouse results in loss of HSCs causing multilineage
bone marrow failure and increased lethality. In
contrast, conditional ablation of Cited2 after lineage
specification in lymphoid and myeloid lineages has
no impact on the maintenance of these lineages.
Additional deletion of Ink4a/Arf (encoding p16Ink4a
and p19Arf) or Trp53 (encoding p53, a downstream
target of p19Arf) in a Cited2-deficient background
restores HSC functionality and rescues mice from
bone marrow failure. Furthermore, we show that the
critical role of Cited2 in primitive hematopoietic cells
is conserved in humans. Taken together, our studies
provide genetic evidence that Cited2 selectively
maintains adult HSC functions, at least in part, via
Ink4a/Arf and Trp53.
INTRODUCTION
Adult hematopoiesis depends on rare multipotent bone marrow
(BM)-resident hematopoietic stem cells (HSCs) (Orkin and Zon,
2008). HSCs may remain quiescent, self-renew, undergo
apoptosis, or differentiate into multiple blood lineages. Tight
regulation of these fates is essential to maintain the adult HSC
pool, and studies in mice have revealed some of the key regula-
tors of HSC maintenance. To identify novel regulators of adult
HSC maintenance, we and others employed comparative global
gene expression approaches. These studies identified the p300/
CBP-binding transcriptional coactivator Cited2 as a candidate
regulator of adult HSCs (Gomes et al., 2002; Mansson et al.,Ce2007; Zhong et al., 2005), but functional validation remains to
be performed.
CITED2 mutations are found in patients with congenital heart
disease (Sperling et al., 2005), lending clinical significance in
trying to understandCITED2 function. Cited2 physically interacts
with the histone acetyltransferase p300/CBP (Bhattacharya
et al., 1999), coactivates DNA-binding transcription factors
(Bamforth et al., 2001; Chou et al., 2006; Glenn and Maurer,
1999; Tien et al., 2004), and represses HIF-1-mediated transcrip-
tion (Bhattacharya et al., 1999). Cited2 has oncogenic properties
(Sun et al., 1998) and controls proliferation of mouse embryonic
fibroblasts (MEFs) via polycomb group genes Bmi-1 and Mel18
and the tumor suppressor Ink4a/Arf (Kranc et al., 2003). Cited2
deletion in mice is embryonic lethal, causing multiple develop-
mental defects (Bamforth et al., 2001; Yin et al., 2002), including
impaired fetal liver hematopoiesis (Chen et al., 2007). Severe
fetal liver malformations (Qu et al., 2007) precluded defining a
cell-autonomous role for Cited2 in HSC function and hematopoi-
esis, although these findings suggest a potential role forCited2 in
fetal HSC regulation. In this study, we use a conditional knockout
strategy to establish a requirement for Cited2 in adult HSCs.
Further, we demonstrate a role for CITED2 in human hematopoi-
esis by RNA interference in CD34+ cord blood (CB) cells.
RESULTS
Cited2 Is Essential for Sustaining Multilineage
Hematopoiesis
Cited2 expression analysis indicated that it is highly expressed in
long-term HSCs (LT-HSCs; LinSca-1+c-kit+(LSK)CD34Flt3
cells), less abundantly in short-term HSCs (ST-HSCs; LSKCD34+
Flt3 cells), and profoundly downregulated in lymphoid-primed
multipotent progenitors (LMPPs; LSKCD34+Flt3+ cells) (Fig-
ure 1A). To investigate a functional requirement for Cited2 in
adult hematopoiesis, we generated Cited2fl/fl Mx1-Cre condi-
tional knockout mice (MacDonald et al., 2008), in which treat-
ment with poly(I)-poly(C) (pIpC) induces efficient gene deletion
in hematopoietic cells (Kuhn et al., 1995). We treated Cited2fl/fl
Mx1-Cre and Cited2fl/fl mice with pIpC (Figure 1B) and refer
to these as Cited2D/D and Cited2fl/fl mice, respectively. Afterll Stem Cell 5, 659–665, December 4, 2009 ª2009 Elsevier Inc. 659
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under the control of the endogenous Cited2 promoter (MacDon-
ald et al., 2008), and efficient gene deletion was demonstrated by
abundant lacZ expression in Cited2D/D BM cells (Figure S1A
available online). Furthermore, Cited2 mRNA was undetectable
in Cited2D/D BM cells (Figure 1C). Within 6 to 15 days after
initiation of pIpC treatment, most Cited2D/D mice became mori-
bund and were sacrificed, in contrast to control mice, which
survived normally (Figure S1B). BM analysis revealed severely
reduced cellularity in Cited2D/D mice (Figure 1D) and strikingly
reduced frequencies of mature myeloid (Mac-1+Gr-1+) and
B-lymphoid (CD19+B220+) cells in Cited2D/D BM, as compared
to control mice (Figure 1E). Conditional loss of Cited2 also
reduced T cell frequencies (Figure 1E). These data support an
essential role for Cited2 in sustaining adult multilineage hemato-
poiesis.
Mx1-Cre mediates gene deletion in both hematopoietic and
nonhematopoietic tissues (Kuhn et al., 1995), so we assessed
the contribution of Cited2 deletion in nonhematopoietic tissues
to morbidity. We transplanted wild-type (WT) BM cells into
Cited2fl/fl Mx1-Cre and Cited2fl/fl mice, and 12 weeks after trans-
plantation, recipients received pIpC. We observed no lethality in
either cohort of mice (Figure S1C), indicating that BM failure in
Cited2D/D mice is the primary cause of mortality.
Cited2 Is Dispensable for the Maintenance
of Committed Blood Lineages
The multilineage defects observed in Cited2D/D mice could
reflect a requirement forCited2 in the maintenance of committed
hematopoietic lineages. To test this hypothesis, we used Cd19-
Cre, LysM-Cre, and Cd4-Cre strains to delete Cited2 in B cell,
Figure 1. Conditional Deletion of Cited2
Results inMultilineageBoneMarrowFailure
(A) Relative expression of Cited2 mRNA in LT-
HSC, ST-HSC, and LMPP populations sorted
from WT C57BL/6J mice. Data are mean ± SEM
(n = 3).
(B) Cited2fl/fl Mx1-Cre and Cited2fl/fl mice received
six injections of pIpC on alternate days and
analyzed 5 days after the last injection.
(C) Relative expression ofCited2mRNA in total BM
cells from Cited2D/D and control mice (mean ±
SEM; n = 3).
(D) Total number of BM nucleated cells obtained
from two tibias and two femurs of Cited2D/D and
control mice. The results are presented as mean
number of cells ± SD (n = 5). *p < 0.0001.
(E) Top and middle: Frequencies of B-lymphoid
and myeloid cells, respectively, in BM from
Cited2D/D and control mice. Bottom: FACS plot
showing CD4 and CD8 staining in thymi from
Cited2D/D and control mice. Data are shown as
mean frequency ± SD (n = 3).
myeloid, and T cell lineages, respectively.
Cd19-Cre efficiently excised Cited2 in
CD19+B220+ cells but did not affect their
frequency in the BM (Figure 2A). Like-
wise, efficient deletion of Cited2 in the
myeloid compartment led to lacZ expres-
sion in the majority of Mac-1+Gr-1+ cells, but did not alter the
frequency of these cells in the BM (Figure 2B). Cd4-Cre effi-
ciently excised Cited2 in T cells but did not change their
frequency in the thymus (Figure 2C). Therefore, Cited2 is
expendable for the maintenance of these committed lineages.
Cited2 Is Required for the Maintenance of Adult HSCs
Next, we addressed the impact of Cited2 deletion on HSC and
progenitor cell activity. In colony-forming cell (CFC) assays,
Cited2D/D BM cells failed to generate colonies in methylcellulose
(Figure 3A). To evaluate HSC activity in vitro, we performed limiting
dilution cobblestone area-forming cell (CAFC) assays and found
thatCited2D/DBM completely lacked CAFCs (Figure 3B). To assess
HSC activity in vivo, we transplanted CD45.2+ BM cells from
Cited2D/D and Cited2fl/fl control mice (with or without WT CD45.1+
BM competitors) into irradiated congenic CD45.1+ recipients.
Without CD45.1+ BM competitors, Cited2D/D BM cells did not
rescue recipient mice from lethal irradiation (data not shown).
Furthermore, CD45.2+ Cited2D/D BM cells transplanted with
CD45.1+ BM competitor cells did not contribute to multilineage
hematopoiesis (Figure 3C). Immunophenotypic analysis of
Cited2D/D BM revealed a near complete loss of cells in the LSK
compartment (Figure 3D) that contains LT-HSCs, ST-HSCs, and
LMPPs.The frequency ofLinSca-1c-Kit+ (LK)myeloid progenitor
cells was also profoundly decreased inCited2D/Dmice. To exclude
the effects of pIpC-induced Cre-mediated toxicity on hematopoi-
etic stem and progenitor cells (HSPCs), we compared the immuno-
phenotypic and functional properties of HSPCs from Cited2+/+
Mx1-Cre and Cited2fl/fl mice and found no apparent differences
(Figures S2A–S2D). These data indicate that pIpC-induced Cre
activity does not phenocopy Cited2 deletion in HSPCs.660 Cell Stem Cell 5, 659–665, December 4, 2009 ª2009 Elsevier Inc.
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suggest a survival defect. To test this, we deleted Cited2 in
cultured LSK cells and demonstrated that the rate of apoptosis
was markedly increased in Cited2D/D cells, as compared to WT
cells (Figure S2E). Thus, decreased survival of LSK cells under-
pins the multilineage BM failure observed in Cited2D/D mice.
Cited2 Functions in a Cell-Autonomous Manner in HSCs
To independently examine whether loss of Cited2D/D HSCs is
caused by Cited2 deletion specifically in the hematopoietic
system, we mixed CD45.2+ BM cells from untreated Cited2fl/fl
Mx1-Cre or Cited2fl/fl mice with CD45.1+ WT BM competitor cells
and transplanted them into irradiated recipients. Eight weeks after
transplantation, the mice received pIpC and five days after the last
dose the percentage of the donor-derived CD45.2+ cells was
analyzed in the BM. The percentage of CD45.2+ Cited2D/D cells
in LSK and LK compartments was significantly reduced compared
to CD45.2+ Cited2fl/fl cells (Figure 3E). These data indicate a cell-
autonomous requirement for Cited2 in HSC maintenance.
CITED2 Is a Regulator of Primitive Hematopoietic
Cell Function in Human Cord Blood
The high evolutionary conservation of Cited2 in mammals (Bhat-
tacharya et al., 1999) suggests a conserved role for Cited2 in
HSC function. We generated a lentivirus expressing short-
hairpin RNA (shRNA) targeting human CITED2 (Figures S3A–
S3D) and performed assays to enumerate LTC-ICs, the most
Figure 2. Cited2 Is Dispensable for the
Maintenance of Mature Lymphoid and
Myeloid Lineages
(A) Left: FACS plots showing CD19 and B220
staining of BM cells obtained from Cited2+/+
Cd19-Cre+/ and Cited2fl/ Cd19-Cre+/ mice.
Results from representative animals are shown
(n = 3). Right: Relative expression of Cited2
mRNA in CD19+B220+ cells sorted from peripheral
blood (PB) ofCited2+/+ Cd19-Cre+/ andCited2fl/
Cd19-Cre+/ mice. Data are mean ± SEM (n = 3).
(B) Left: FACS plot showing Mac-1 and Gr-1 stain-
ing of BM cells obtained from Cited2fl/+ LyzM-
Cre+/ and Cited2fl/ LyzM-Cre+/ mice. Data are
shown as mean frequency ± SD (n = 3). Right:
LacZ staining of BM Mac-1+Gr-1+ cells from
Cited2fl/+ LyzM-Cre+/ and Cited2fl/ LyzM-Cre+/
mice.
(C) Left: FACS plots showing distribution of T cell
subsets in the thymi of Cited2fl/fl and Cited2fl/fl
Cd4-Cre mice. Data are shown as mean fre-
quency ± SD (n = 3). Right: Relative expression
of Cited2 mRNA in CD4+ and CD8+ cells sorted
from PB of Cited2fl/fl and Cited2fl/fl Cd4-Cre
mice. Data are mean ± SEM (n = 3).
primitive human progenitors assessable
in vitro. CB CD34+ cells transduced with
shRNA and control lentiviruses were co-
cultured on stromal cells. CITED2 knock-
down in CD34+ cells led to a severe
reduction in cellularity over time,
compared to CD34+ cells transduced
with a control lentivirus (Figure S3E). Furthermore, CITED2
knockdown in CD34+ cells strikingly impaired primitive hemato-
poietic cell activity, as judged by LTC-IC assays (Figure 3F).
Thus, our data indicate that CITED2 is a conserved regulator of
primitive hematopoietic cell function in mammals. Furthermore,
with this Mx1-Cre-independent model system, we corroborate
the data obtained in our conditional mouse model.
Intact Ink4a/Arf and Trp53 Are Required for the Loss
of Cited2D/D HSCs
We previously showed that Cited2 null MEFs senesce prema-
turely and have increased levels of p16Ink4a and p19Arf (Kranc
et al., 2003), whereas ectopic expression of Cited2 represses
p16Ink4a and p19Arf, enhancing MEF proliferation. Deletion of
Ink4a/Arf or Trp53 (encoding p53, a downstream target of
p19Arf), rescued defective proliferation in Cited2/ MEFs
(Figure S4A; Kranc et al., 2003). Ink4a/Arf and Trp53 are essential
in maintaining HSC function (Akala et al., 2008), so we hypothe-
sized their involvement in the loss of Cited2D/D HSCs. Consistent
with this, Cited2 deletion in LSK cells resulted in an increased
expression of p19Arf and p53 proteins and a p53 target
gene Cdkn1a (Figures S4B–S4D). Next, we generated Cited2fl/fl
Mx1-Cre Trp53+/, Cited2fl/fl Mx1-Cre Trp53/, Cited2fl/fl
Mx1-Cre Ink4a/Arf +/, and control mice and treated them with
pIpC. Q-PCR confirmed that Cited2 was not expressed in
Cited2D/D BM cells, regardless of Ink4a/Arf and Trp53 status (Fig-
ure S4E). Deletion of one Ink4a/Arf allele or one or two alleles ofCell Stem Cell 5, 659–665, December 4, 2009 ª2009 Elsevier Inc. 661
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Critical Role of Cited2 in Adult HSC MaintenanceFigure 3. Cited2 Maintains HSCs in a Cell-Autonomous Manner
Cited2fl/fl Mx1-Cre and control mice were treated with pIpC as shown in
Figure 1B.
(A) CFC assay performed on total BM cells from Cited2D/D and control mice.
The graph shows the mean number of CFC colonies ± SD counted on day
10 (n = 3 per group).
(B) CAFC assay. The graph shows the mean number of cobblestone areas ±
SEM counted at week 5 (n = 3).
(C) Competitive repopulation assay. CD45.2+ BM cells from Cited2D/D or
control mice were mixed with CD45.1+ WT competitor BM cells and trans-
planted into irradiated CD45.1+ WT recipients. After 16 weeks, the contribution
of CD45.2+ cells was analyzed. Data are mean percentage of CD45.2+ cells in
PB of recipient mice ± SD (n = 6 per group).
(D) Frequencies of the BM LSK and LinSca-1c-Kit+ (LK) cells fromCited2D/D,
Cited2+/D, and Cited2fl/fl control mice. The data are representative of four
independent experiments.
(E) BM cells from untreated Cited2fl/fl Mx1-Cre and Cited2fl/fl mice were mixed
with CD45.1+ WT competitive BM and transplanted into irradiated recipients.
Eight weeks after tansplantation, the mice were treated with five doses of
pIpC. Five days after last pIpC administration, the percentage of test
CD45.2+ cells was measured in BM LSK and LK compartments. Data are
mean ± SD (n = 3). *p < 0.001; **p < 0.0002.
(F) LTC-IC assay. Human CD34+ CB cells transduced with shRNA and control
lentiviruses were cocultured with MS5 stromal cells. After 5 weeks, medium
was replaced with complete methylcellulose. The graph shows the mean
percentage of GFP+ LTC-IC colonies in cultures ± SD (n = 2) scored 2 weeks
after adding methylcellulose.662 Cell Stem Cell 5, 659–665, December 4, 2009 ª2009 Elsevier IncTrp53 restored total BM cellularity in Cited2D/D mice to the levels
observed in Cited2fl/fl control mice (Figures 4A and 1D). Ablation
of one allele ofTrp53also rescued B cell and myeloid development
in Cited2D/D BM (Figure 4B). Furthermore, deletion of one allele of
Ink4a/Arf or one or two alleles ofTrp53 restored BMCited2D/D LSK
cells (Figure 4C). BM cells from Cited2D/D Trp53+/, Cited2D/D
Trp53/, and Cited2D/D Ink4a/Arf +/, but not Cited2D/D, mice
efficiently generated multilineage colonies in methylcellulose
(Figure 4D). After confirming that Cited2D/D Trp53+/, Cited2D/D
Trp53/, andCited2D/D Ink4a/Arf +/ cells from primary colonies
lacked Cited2 expression, we demonstrated efficient generation
of secondary colonies (data not shown).
To examine whether HSCs lacking both Cited2 and Trp53 have
long-term repopulating capacity, we transplanted Cited2D/D
Trp53+/+, Cited2D/D Trp53/, and Cited2fl/+ Trp53/ total BM
cells (mixed with WT support BM cells) into irradiated recipients
and analyzed peripheral blood (PB) 16 weeks after transplantation.
Cited2D/D Trp53+/+ BM cells failed to repopulate recipients
(Figure 4E), whereas BM cells lacking bothCited2andTrp53 repo-
pulated recipients to a similar extent as those lacking Trp53 with
intact Cited2. To corroborate this, we transplanted BM cells from
untreated Cited2fl/fl Mx1-Cre Trp53+/+ and Cited2fl/fl Mx1-Cre
Trp53+/ mice into irradiated recipients (Figure 4F). After reconsti-
tution, the recipients were treated with pIpC and analyzed 8 weeks
after administration of the last dose. We measured the percentage
of donor cell chimerism in PB nucleated cells or myeloid cells of
recipients by using lacZ as a marker of Cited2-deficient cells.
Whereas Cited2D/D Trp53+/+ cells failed to sustain hematopoiesis,
those lacking Cited2 and one allele of Trp53 showed significant
donor-derived contribution (Figure 4G). Together, these data
provide genetic evidence that the loss of HSCs in Cited2D/D mice
is, at least in part, mediated by Ink4a/Arf and Trp53.
DISCUSSION
In this report, we investigate the requirement for Cited2 in adult
HSCs maintenance and committed hematopoietic lineages. By
using an inducible conditional knockout approach in adult
mice, we demonstrate that Cited2 deletion results in an acute
loss of HSCs, at least in part via apoptosis, subsequently causing
multilineage BM failure. Specific deletion of Cited2 within the
hematopoietic system demonstrates a cell-autonomous require-
ment for Cited2 in maintaining adult HSC integrity, whereas
deleting Cited2 in committed lymphoid and myeloid lineages
has no impact. Furthermore, CITED2 knockdown in human
CD34+CB reveals a conserved requirement for Cited2 in HSC
maintenance. Together, our data provide evidence that Cited2
functions in a cell-autonomous manner to maintain HSCs.
Genetic evidence indicates that the tumor suppressors Ink4a/
Arf and Trp53 regulate multiple HSC fate decisions (Akala et al.,
2008; Liu et al., 2009; Oguro et al., 2006). One function of p19Arf is
to stabilize p53 (Pomerantz et al., 1998), and the activation of the
p19Arf-p53 pathway results in loss of HSCs (Park et al., 2003). We
showed that loss of Cited2 increased p19Arf and p53 expression
in the LSK compartment. Based on this observation, we used
a genetic rescue approach to test whether Ink4a/Arf and Trp53
are required for loss of HSCs lacking Cited2. Our results demon-
strated that deletion of Ink4a/Arf or Trp53 restored functionality
of HSCs lacking Cited2, implying that Cited2 maintains HSCs,.
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Critical Role of Cited2 in Adult HSC MaintenanceFigure 4. Genetic Deletion of Trp53 or Ink4a/Arf Restores HSC Functions and Rescues Bone Marrow Failure in Cited2 D/D Mice
Mice of indicated genotypes were treated with pIpC.
(A) Total BM cellularity from two tibias and two femurs. The results are presented as mean number of cells ± SD (n = 3 per genotype). *p < 0.002 versus remaining
genotypes.
(B) Graphs show total number of BM CD19+B220+ cells (B cells) and Mac-1+Gr-1+ cells (myeloid cells) in two tibias and two femurs per mouse. Mean values ± SD
(n = 4). *p < 0.005 versus remaining genotypes.
(C) Frequencies of the BM LSK cells from mice of indicated genotypes. FACS plots are representative of three independent experiments.
(D) CFC assay. Nucleated BM cells were plated in methylcellulose medium. Cultures were assessed on day 10 for granulocyte (CFC-G), macrophage (CFC-M),
granulocyte-macrophage (CFC-GM), erythroid (E), and mixed (Mix) colony formation. The data are representative of three independent experiments and are
shown as the mean ± SD (n = 2 mice per genotype).
(E) Contribution of donor cells from Cited2fl/+ Trp53/, Cited2D/D Trp53+/+, and Cited2D/D Trp53/ mice to the myeloid compartment of PB 16 weeks after
transplantation. BM cells from mice of the indicated genotypes were mixed with support WT BM cells and transplanted into irradiated recipients. The graph shows
the mean (±SD) percentage of CD45.2+ cells in myeloid compartment of recipient mice (n = 3 per group). *p < 0.0003 versus remaining genotypes.Cell Stem Cell 5, 659–665, December 4, 2009 ª2009 Elsevier Inc. 663
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Critical Role of Cited2 in Adult HSC Maintenanceat least in part, via Ink4a/Arf and Trp53. These data support the
postulate that deletion of Cited2 in HSCs results in activation of
the p19ARF-p53 pathway and thereby leads to their loss.
It is of interest to relate Cited2 to other critical regulators of
HSC maintenance. Cited2 is required for Bmi-1 expression in
MEFs (Kranc et al., 2003) and myeloid progenitors (Chen et al.,
2007). Bmi-1 maintains HSCs (Lessard and Sauvageau, 2003;
Park et al., 2003) and directly represses Ink4a/Arf (Bracken
et al., 2007), whereas deletion of Ink4a/Arf (Oguro et al., 2006)
or Trp53 (Akala et al., 2008) restores Bmi-1/ HSC function.
Genetic evidence indicates distinct roles for Bmi-1 and Cited2
in HSC fate decisions. Whereas Bmi-1 mediates HSC self-
renewal, our results are compatible with a requirement for
Cited2 in HSC survival. In agreement with this, acute Cited2
deletion in HSCs does not affect the expression of Bmi-1 (data
not shown), suggesting that downregulation of Bmi-1 expres-
sion is not responsible for the loss of Cited2D/D HSCs. However,
this does not exclude the possibility that Cited2 controls Bmi-1
in other contexts in HSCs. Conditional deletion of Cited2 gener-
ates a stem cell phenotype reminiscent of conditional inactiva-
tion of Tel/Etv6 and Mcl-1 (Hock et al., 2004; Opferman et al.,
2005). Like Tel/Etv6 (Hock et al., 2004), Cited2 appears to be
selectively required for HSC maintenance, but dispensable for
mature lineages. Mcl-1, however, also plays critical roles in
mature T and B cell survival (Opferman et al., 2003), revealing
a broader spectrum of hematopoietic function than Cited2.
Conditional deletion of Apc and combined deficiency of c-Myc
and N-Myc (but not ablation of N-Myc alone) results in loss of
HSCs (Laurenti et al., 2008; Qian et al., 2008). Although the
expression of Apc and c-Myc is unaltered in Cited2-deficient
HSCs, the expression of N-myc is decreased (data not shown).
Although this observation alone does not explain the loss of
Cited2-deficient HSCs, N-Myc may mediate some functions of
Cited2 in HSCs. Finally, Cited2 binds p300 and its paralog
CBP (Bhattacharya et al., 1999). Although Cbp is essential for
adult HSC maintenance, p300 appears dispensable for HSC
maintenance but required for multilineage hematopoietic differ-
entiation (Kung et al., 2000; Rebel et al., 2002). It will be of
interest to clarify the roles of Cbp-Cited2 and p300-Cited2 inter-
actions in adult HSC maintenance and hematopoiesis, and the
relationship between Cited2 and other critical stem cell regula-
tors remains an open question meriting future investigation.
In conclusion, we provide genetic evidence that Cited2 is an
essential and cell-autonomous regulator of adult mammalian
HSC maintenance. Our data, together with the sufficiency of
Cited2 to maintain undifferentiated embryonic stem cells
(Pritsker et al., 2006), suggest that it is a critical master regulator
of stem cell fate. Understanding Cited2 functions at the molecular
level will offer insights into the similarities and differences in the
transcriptional circuitry of embryonic and somatic stem cells.
EXPERIMENTAL PROCEDURES
Mice
We backcrossed Cited2fl/fl and Cited2+/ mice (Bamforth et al., 2001; Mac-
Donald et al., 2008) to C57BL/6J for ten generations to generate coisogenicmice.Mx1-Cre,Cd19-Cre, and LysM-Cremice were purchased from the Jack-
son Laboratory. Cd4-Cre mice were purchased from Taconic. Ink4a/Arf +/
and Trp53+/ mice were obtained from B. Hassan and M. van Lohuizen,
respectively. All experiments on animals were performed under UK Home
Office authorization.
Administration of pIpC
8- to 12-week-old mice received five to six intraperitoneal injections of pIpC
(GE Healthcare; 0.2–0.3 mg per dose) every alternate day. Deletion efficiency
was determined by Q-PCR or lacZ expression analysis (via a FluoReporter
lacZ Flow Cytometry Kit, Invitrogen).
Murine CAFC Assay
Stromal layers were prepared from the BM of C57BL/6J mice, irradiated at
15 Gy, and subcultured in 96-well flat-bottom plates at a density of 2 3 104
cells per well. After 1 to 7 days, cultures were seeded at 2-fold dilutions
(2.93 10518,125 per well) of nucleated BM cells from each genotype. CAFCs
were scored at week 5.
CFC Assays
H4434 and M3434 media (StemCell Technologies) were used to enumerate
human and mouse colony-forming cells, respectively. Two replicates were
used per group in each experiment. Colonies were tallied at day 10–14.
Q-PCR
RNA extraction and Q-PCR reactions were performed as previously described
(Mansson et al., 2007). For specific TaqMan Assays-on-Demand probes used,
see Supplemental Experimental Procedures. Reactions were run on an
Applied Biosystems 7500 Fast Real-Time PCR System in normal mode for
50 cycles. All experiments were performed in triplicate. Differences in input
cDNA were normalized with a combination of Hprt, Gapdh, Actb, Ubc, and
B2m expression with qBase 1.3.5 software (http://medgen.ugent.be/qbase/).
Lentiviral Transductions
CITED2 shRNA was subcloned from the pLKO.1 puro vector (Open Biosys-
tems) into the pLKO.1 GFP vector (gift from J. Larsson). Lentivirus production
and transduction of human CD34+ CB cells are described in Supplemental
Experimental Procedures.
Human Long-Term Cultures on Stroma and LTC-IC Assays
CB CD34+ cells (StemCell Technologies) were isolated by MiniMACS (Miltenyi
Biotec) selection. After transduction, 3 3 104 cells were cultured on MS5
stromal cells in Long-Term Culture medium (see Supplemental Experimental
Procedures). Cultures were demidepopulated weekly for analysis. LTC-IC
numbers were enumerated by overlaying MS5 stromal cocultures at week 5
with H4434 medium, followed by counting colonies 2 weeks later.
FACS
All samples were analyzed on a CyAn ADP flow cytometer (Dako). Sorts were
performed on FACSAriaIIu (BD) or MoFlow (Dako) cell sorters. Antibodies are
described in Supplemental Experimental Procedures.
Competitive Repopulation Assay
CD45.2+ test donor BM cells were mixed with CD45.1+ competitor BM cells
in a 1:1 ratio and injected intravenously into lethally irradiated (9 Gy) B6.SJL
CD45.1+ recipients. The competitor cell number was 53 105 cells in all experi-
ments.
Statistical Analysis
Statistical significance was determined via two-tailed Student’s t tests
assuming unequal variance.(F) Schematic of experimental design.
(G) Contribution of donor cells of the indicated genotypes to PB. Percentage of lacZ+ donor cells was analyzed by flow cytometry in total PB mononuclear
compartment and myeloid (Mac-1+Gr-1+) compartment of recipients (n = 5 per group). *p < 0.002; **p < 0.00008.
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